The prodrug approach in the era of drug design

Expert Opin Drug Deliv. 2019 Jan;16(1):1-5. doi: 10.1080/17425247.2019.1553954. Epub 2018 Dec 18.

Authors

Anas Najjar¹, Rafik Karaman¹

Affiliation

¹ a Department of Bioorganic & Pharmaceutical Chemistry, Faculty of Pharmacy , Al-Quds University , Jerusalem , Palestine.

PMID: 30558447
DOI: 10.1080/17425247.2019.1553954

No abstract available

Keywords: Baloxavir marboxil; FDA approved; drug design; fosnetupitant; latanoprostene bunod; prodrugs; strategies; success; tafenoquine.